Building on the observation that IIT is associated with response to a-PD1, we investigated whether coordinated delivery of TA, IFNα, and IL-12 could restore response to a-PD1 in mouse tumor models that normally do not respond to checkpoint inhibition, such as B16-F10 melanoma LM41. The gene discussed is IFNA1; the disease is neoplasm.